Significant Ownership of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Signature - Title
/s/ Yuqing Chen - Yuqing Chen / Chairman
Location
Shanghai, China
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Shanghai Fosun Pharmaceutical (Group) Co., Ltd..

Notify me when Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NATR NATURES SUNSHINE PRODUCTS INC Common Stock, no par value 0.35% $735,354 -$32,713,796 64,167 -97.8% Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25 Jun 2025

Schedules 13D/G Reported by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.